SCHEMBL10201034

SCHEMBL10201034

COC(=O)C(C)(C)C(c1cccc(F)c1)c1ccc(N2CCCCC2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.36
CHRNB2 P17787 1/20 0.36
SLC6A2 P23975 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
SLC6A3 Q01959 1/20 0.36
TSHR P16473 3/20 0.35
MAPK1 P28482 1/20 0.35
CACNA1G O43497 1/20 0.35
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ADORA2A P29274 1/20 0.34
CHRM3 P20309 2/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL752315 0.90 MAPT (0.40) SMN1; SMN2NPC1MAPTRAB9AADORA2A
SCHEMBL10201035 0.90 KCNQ2 (0.39) KCNQ2SMN1; SMN2CHRNB2SLC6A2CHRNB4
SCHEMBL753423 0.80 AR (0.40) SMN1; SMN2MAPK1NPC1TP53MAPT
SCHEMBL14207676 0.79 HDAC4 (0.38) TSHRCACNA1GCYP2C9CYP2C19HDAC4
SCHEMBL753573 0.79 HDAC4 (0.41) SMN1; SMN2TSHRCACNA1GCYP2C9CYP2C19
SCHEMBL765706 0.78 HDAC4 (0.36) SMN1; SMN2TSHRCACNA1GCYP2C9CYP2C19
SCHEMBL14207516 0.73 MAPT (0.34) SMN1; SMN2NPC1MAPTRAB9AADORA2A
SCHEMBL751383 0.73 NR3C1 (0.50)
SCHEMBL753470 0.73 NR3C1 (0.50)
SCHEMBL2895526 0.69 MAPT (0.52) KCNQ2SMN1; SMN2TSHRNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed